Log in
Enquire now
‌

US Patent 10335428 P-ethoxy nucleic acids for liposomal formulation

Patent 10335428 was granted and assigned to Bio-Path Holdings on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Bio-Path Holdings
Bio-Path Holdings
0
Date Filed
July 21, 2017
0
Date of Patent
July 2, 2019
0
Patent Applicant
Bio-Path Holdings
Bio-Path Holdings
0
Patent Application Number
15657083
0
Patent Citations Received
‌
US Patent 12012601 Combination therapy with liposomal antisense oligonucleotides
0
‌
US Patent 10898506 P-ethoxy nucleic acids for liposomal formulation
‌
US Patent 10927379 Combination therapy with liposomal antisense oligonucleotides
‌
US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition
Patent Inventor Names
Peter Nielsen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10335428
0
Patent Primary Examiner
‌
Tracy Vivlemore
0

Find more entities like US Patent 10335428 P-ethoxy nucleic acids for liposomal formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.